
Article 1 
The Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.
Article 2 
This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.
This Regulation shall be binding in its entirety and directly applicable in all Member States.Done at Brussels, 29 November 2019.
For the Commission
The President
Jean-Claude JUNCKER
ANNEX

Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows:

((1)) in the sixth column, expiration of approval, of row 57, Mecoprop-P, the date is replaced by ‘31 January 2021’;
((2)) in the sixth column, expiration of approval, of row 81, Pyraclostrobin, the date is replaced by ‘31 January 2021’;
((3)) in the sixth column, expiration of approval, of row 114, Mancozeb, the date is replaced by ‘31 January 2021’;
((4)) in the sixth column, expiration of approval, of row 115, Metiram, the date is replaced by ‘31 January 2021’;
((5)) in the sixth column, expiration of approval, of row 116, Oxamyl, the date is replaced by ‘31 January 2021’;
((6)) in the sixth column, expiration of approval, of row 128, Dimoxystrobin, the date is replaced by ‘31 January 2021’;
((7)) in the sixth column, expiration of approval, of row 187, Flutolanil, the date is replaced by ‘28 February 2021’;
((8)) in the sixth column, expiration of approval, of row 188, Benfluralin, the date is replaced by ‘28 February 2021’;
((9)) in the sixth column, expiration of approval, of row 189, Fluazinam, the date is replaced by ‘28 February 2021’;
((10)) in the sixth column, expiration of approval, of row 191, Mepiquat, the date is replaced by ‘28 February 2021’.
